CSIMarket
 




Harmony Biosciences Holdings inc   (HRMY)
Other Ticker:  
 
 



HRMY Price to Cash Flow Ratio (Dec 31 2023) (Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Cash Flow Trailing 12 Months IV. Quarter III. Quarter II. Quarter I. Quarter IV. Quarter
Price to Cash Flow (TTM) Ratio current            28.74            35.86            30.39            45.37            45.37
Cashflow TTM Y / Y Change - % -25.62 % -7.73 % -35.21 % - %
Cashflow Y / Y Change - % -71.03 % 140.59 % - % - %
Stock performance to date 30.59 % -30.74 % 7.97 % -33.13 % -18.71 %

Price to Cash Flow ratio Comment
Despite shareprice increase of 30.59 %, from beginning of IV. Quarter Harmony Biosciences Holdings Inc 's current Price to Cash Flow ratio has contracted due to Cash flow growth of -52.2 %, to Price to Cash Flow of 28.74, from average Price to Cash Flow ratio in III. Quarter of 35.86.


What is Price to Cash Flow Ratio?
Valuation in Major Pharmaceutical Preparations Industry

Price to Cash Flow ratio Company Ranking
Within: No.
Industry #0
Sector #4
S&P 500 #68






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com